Stay updated with breaking news from Nasdaq Tals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $28.28 and last traded at $26.18, with a volume of 129563 shares traded. The stock had previously closed at $26.50. Talaris Therapeutics Stock Performance The company has a […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) announced a dividend on Wednesday, October 18th, NASDAQ reports. Shareholders of record on Monday, October 16th will be paid a dividend of 1.5118 per share on Friday, October 20th. The ex-dividend date is Friday, October 20th. Talaris Therapeutics Price Performance Shares of Talaris Therapeutics stock opened at […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) announced a dividend on Tuesday, October 10th, NASDAQ reports. Investors of record on Monday, October 16th will be given a dividend of 1.5118 per share on Friday, October 20th. The ex-dividend date is Friday, October 20th. Talaris Therapeutics Price Performance Talaris Therapeutics stock opened at $2.69 on […]
Talaris Therapeutics (NASDAQ:TALS – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends. Analyst Recommendations This is a summary of […]
Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily volume of 629,200 shares, […]